Can Psychedelics like MDMA Cure Eating Disorders?
Anyone who has ever suffered from an eating disorder, such…
mdma
Mind Cure Health Halts All Psychedelic Business Activity
The company was pursuing several psychedelic business strategies, including synthesizing ibogaine for researchers.
Top 5 Most Influential Psychedelic Studies
We unpack five of the most important psychedelic studies conducted in recent years as psychedelics become mainstream medicine.
How Long Until Psychedelic Stocks Payoff?
Our resident Psychedelic Investor explores one of the biggest questions on minds of those investing in psychedelic stocks.
How Rick Doblin Guides Someone Through a Bad Psychedelic Trip
Difficult trips could be a problem in areas where psychedelics have been decriminalized, which is why MAPS will offer a psychonaut training program.
Psychedelic Business Spotlight – January 21
Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds
Americans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety, and PTSD.
Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy
New amendment reverses a 2013 Health Canada policy that prevented “a letter of authorization for a new drug that is or that contains a restricted drug.”
2021: A Year in Review for the Psychedelics Business
Our resident Psychedelic Investor looks back at some of this growing industry’s biggest moments and how they may shape the business in 2022.
Texas Further Embraces Psychedelics with Launch of Center for Psychedelic Research and Therapy
Research will focus on how various psychedelics can be used under proper supervision and guidance to treat severe depression, anxiety and PTSD.
End of content
End of content